ArticleBMC infectious diseases2025
A prognostic model for early risk stratification in adult community-acquired suspected CNS infections: multicenter development and external validation.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04722328 (Establishment of Prevention and Control System of Central Nervous System Infection), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Establishment of Prevention and Control System of Central Nervous System Infection
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
objectiveCommunity-acquired central nervous system (CNS) infections remain a major cause of morbidity and mortality, particularly in resource-limited settings. Early prognostication is critical but challenged by delays in definitive diagnosis. This study aimed to develop and externally validate a simple prognostic model to support early risk stratification and intervention.
methodsWe conducted a prospective multicenter cohort study in China (NCT04722328), enrolling 1,060 adults with suspected CNS infections. Patients from four hospitals were included in the training group (n = 742) for model development, while patients from three independent hospitals formed the external validation group (n = 318). Independent predictors were identified using least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression. A nomogram was constructed to estimate individualized risk. Model performance was assessed via area under the receiver operating characteristic curve (AUC), concordance index (C-index), calibration plots, decision curve analysis (DCA), and clinical impact curves (CICs).
resultsSix predictors were independently associated with poor outcomes: absence of headache, altered consciousness, respiratory failure, hypoproteinemia, low hemoglobin, and hyperglycemia. The model demonstrated strong discrimination in the training group (AUC 0.811; 95% CI 0.774–0.849) and excellent calibration, with DCA indicating clear clinical benefit. External validation confirmed robust performance (AUC 0.855; 95% CI 0.800–0.910), supporting the model’s generalizability.
conclusionWe established a prognostic model to support early identification of severe cases and guide timely comprehensive management in adult patients with suspected community-acquired CNS infections. CLINICAL REGISTRATION: ClinicalTrials.gov (NCT04722328).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.